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Summary.-Lymphocytes of lymphocyte-rich pleural effusions and venous blood
from 16 cancer patients, 7 patients with benign pleural effusions and blood from 23
normal blood donors, were examined for cytological features, rosette-forming
capacity, immunofluorescent staining, and PHA-stimulated DNA synthesis. Total
protein and immunoglobulin levels were also determined. Metastatic effusions
revealed 40° higher content of immunoglobulins G, A and M (P<0 002) as well
as of total protein (P<0.005) than non-metastatic pleural effusions. However, the
serum of the non-cancer patients contained .- 50O higher level of Ig than in cancer
patients (P<0 001). Whilst there was no significant difference in the relative- T- or
B-cell contents of pleural effusions between cancer and non-cancer patients (P>005)
spontaneous proliferation of lymphocytes was significantly increased (P>0.01),
which led to a lower PHA-stimulated transformation index in pleural effusions from
cancer patients than in all other lymphocyte sources examined (P<0 001).
METASTATIC PLEURAL EFFUSIONS of
patients suffering from cancer of different
organs sometimes contain very high num-
bers of lymphocytes (Yam, 1967; Lopes
Cardozo & Harting, 1972). Yamagishi et
al. (1976) found in patients with broncho-
genic carcinoma that good clinical con-
ditions were associated with high percent-
ages of lymphocytes, whereas a deteriora-
tion ofthe clinical status was paralleled by
an increase of macrophages in the pleural
effusions, suggesting that a high number
of lymphocytes is able to limit the extent
of the disease for a certain period. Apart
from this observation, nothing is known
about the immunological importance and
function of lymphocytes in lymphocyte-
rich pleural effusions. In these effusions,
metastatic cells and lymphocytes appear
to live under optimum conditions of
metabolism and nutrition (Sauter, 1971).
Since these cells are accessible and can be
studied repeatedly, lymphocytes from
metastatic pleural effusions appear to be
a good natural model for the study ofsome
aspects of the immunological defence
against malignant cells.
For this investigation, we selected
pleural effusions rich in lymphocytes. We
used various methods to characterize
lymphocytes immunologically, and com-
pared lymphocytes from metastatic pleural
effusions with those from "benign" pleural
effusions, as well as with peripheral blood
lymphocytes from both patient groups
and from normal controls, in order to
evaluate the lymphocyte responses charac-
teristic of malignant effusions.
MATERIALS AND METHODS
Patients.-Twenty-three adult patients
with recently diagnosed pleural effusions
were examined. Effusions had been pre-
screened by cytological examinations, and
the numbers of lymphocytes had been deter-
mined in order to select effusions with 105 or
more lymphocytes per ml pleural fluid for the
metastatic pleural effusions. The "cancer
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patients" (n= 16) had cancer of the lung or
breast complicated by metastatic effusions to
the pleural cavity. Four patients had been
irradiated in previous years, and their reac-
tions in the PHA-stimulation assay were not
considered, in order to exclude possible long-
term effects ofradiation on the PHA response
(Hoppe et al., 1977). The "non-cancer
patients" (n =7) had congestive heart failure.
Pleuraleffusions with at least 104lymphocytes
per ml w%Nere selected for this group in order to
get a reasonable number of non-metastatic
pleural effusions for comparison. The pleural
effusions from only 3 patients contained
enough lymphocytes to measure the PHA
response reliably after a 1 I-year period of
sampling in our and neighbouring hospitals.
None of the patients had received immuno-
suppressive chemotherapy.
Twenty-three healthy blood donors served
as a control in the standardization of the
methods. They ranged in age from 23 to 41
years, with a mean of 30 years. Males pre-
dominated (74%).
Separation of lymphocytes and identification
of cells.-Blood was taken by routine vene-
puncture and anticoagulated with preserva-
tive-free heparin (20 u/ml). Patients with
pleural effusions were asked to change their
body positions at short intervals before
puncture of the pleural cavity. Pleural fluid
was also anticoagulated with preservative-
free heparin (20 u/mI).
Mononuclear cells were separated from the
peripheral bloodonaFicoll-Hypaque gradient
using the method of B0yum (1968). Cells of
the pleural effusions were concentrated by
centrifugation to a concentration of at least
109 cells/l before separation. Separation was
done by the same method. The cells were then
washed x 3 and resuspended in RPMI 1640
medium. The whole procedure was carried
out under sterile conditions.
Identification of cells-.Before and after
separation of the lymphocytes, smears of
venous blood and pleural effusions were pre-
pared and stained panoptically with May-
Grunwald-Giemsa. In order to identify mono-
nuclear macrophages and monocytes, addi-
tional smears were prepared and cyto-
chemically analysed for nonspecific esterase
activity by means of a slight modification of
the cx-naphthyl acetate assay ofLoffler (1961).
Pleural effusions which yielded > 1% macro-
phages or tumour cells after lymphocyte
separation w^ere excluded from the study.
Rosette test.-Mononuclear cells were sus-
pended in RPMI 1640 containing 25mM
Hepes buffer and 2% L-glutamine at a con-
centration of 2 x 109 cells/l. 0-2 ml washed
sheep red blood cells (SRBC) were absorbed
1:1 with foetal calf serum (FCS) and added
to 1 ml suspension of mononuclear cells. Cells
were incubated for 5 min at 22°C, pelleted for
5 min at 60 g, and stored at 4°C overnight.
After gentle resuspension, 0-02 ml was placed
on a slide, 5 ,lI trypan blue was added, and
this mixture was covered with a cover glass.
Cells were examined with a Normarsky
microscope and classified as: (1) rosette-
forming cells (RFC) when at least 3 SRBC
attached to their surface, (2) blue-stained
non-vital lymphocytes, or (3) non-rosette-
forming cells (non-RFC). Monocytes were
excluded by nonspecific esterase staining
(Aiuti et al., 1975).
Immunofluorescent staining. Mononuclear
cells were resuspended in RPMI 1640 at a
concentration of 1010 cells/l, kept for 30 min
at 37°C, washed, and incubated for 30 min at
4°C with fluorescein-conjugated monospecific
(IgG, IgA, or IgM) antisera from goat supple-
mented with 0.02% sodium azide. Cells w%Nere
washed x 3 with PBS and the pellet re-
suspended in PBS-glycerol. Two drops were
placed on a slide, covered, and examined
with an epi-illuminated fluorescence micro-
scope. Cells were classified as surface immuno-
globulin-bearing cells (SIgBC) or non-SIgBC
(Aiuti et al., 1975; Horwitz & Lobo, 1975).
PHA-stimulated DNA synthesis.-Under
sterile conditions, mononuclear cells were re-
suspended at a concentration of 109 cells/I in
RPMI 1640 supplemented with 15% FCS,
15mM Hepes buffer, 2% L-glutamine, 100
iu/ml penicillin, and 0-1 mg/ml streptomycin.
Phytohaemagglutinin (PHA-P from DIFCO,
Detroit, Michigan, U.S.A.) was dissolved in
5 ml bidistilled water and passed through a
Millipore filter. Mononuclear cells were cul-
tured in microtitre plates and supplemented
with 0-025ml aliquots ofa 0 025% dilution of
PHA-P per ml cell suspension. Cells were
incubated in a 500 CO2-air environment at
37°C and 100% relative humidity for 72 h.
Six hours before harvesting, 0 5 ,uCi 3H-
thymidine was added to each culture. After
a total of 78 h, cells were collected on fibre-
glass filters using an automated cell harvester.
The rate ofDNA synthesis was determined by
measuring the [3H]-dT uptake of the cells by
liquid-scintillation counting. After correction
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of quenching, the results for each group of
patients were expressed as the mean dis-
sociations per minute (d/min) for stimulated
and unstimulated cultures, or as the trans-
formation index (TI) according to Yamamura
(1973), which is the ratio of the d/min of
stimulated cultures to the d/min of unstimu-
lated cultures.
Protein and immunoglobulin assays-.Pro-
tein electrophoresis was carried out on agarose
matrices with the standard method. Quanti-
tative immunoelectrophoresis was performed
by radioimmunodiffusion on standardized
IgG, IgM and IgA plates (Behring, Marburg,
Germany). A reference curve for each protein
component was established using the stand-
ards supplied by the manufacturer. The con-
centrations of the various immunoglobulins
were determined by comparing the developed
precipitation rings with the calibrated refer-
ence curve.
Statistical comparisons and normal values.-
The mean and standard deviation (s.d.) were
determined for each group. Mean values were
compared by means of the non-parametric
U-test of Mann and Whitney, because this
test does not require a Gaussian distribution
of measured values, and is nearly as efficient
as Student's t test.
The healthy blood donors showed the
following values (mean + s.d.): lymphocytes
2-34 + 0-86 x 109/1; RFC 70 9 + 7-5%; SIgBC
10 1+ 3-0o; null cells 19-9 +2.2%; T-cell/
B-cell ratio: 7 0: 1; TI: 39-2 + 6-6.
RESULTS
Cancer patients had cytologically estab-
lished metastases to the pleural cavity.
The pleural effusions contained a variable
number of malignant cells (0-02-50 x
106/1).
In the non-cancer patients, cancer was
excluded by all available diagnostic
methods, including a follow-up examina-
tion several months after analysis of their
effusions. Their pleural effusions contained
only benign cells.
The average value of lymphocytes in
the venous blood (Table I) for the group
of non-cancer patients is normal for this
age group (Rosenthal & Steinmann, 1978).
Cancer patients had a slightly, but signifi-
cantly (P < 0.05) lower average. A 9-fold
higher mean lymphocyte count was seen in
the pleural effusions of cancer patients
(P < 0-001) under the conditions of our
selection.
Lymphocyte subpopulations
The average number of T cells (RFC) in
peripheral blood of cancer patients (0.905
x 109/1) was slightly lower than in non-
cancer patients (1.161 x 109/1) but the
difference was not significant (P > 0 05).
Both values lie in the normal range for
this age group (Rosenthal & Steinmann,
1978).
While the absolute concentration of T
cells in pleural effusions of cancer patients
was considerably higher, there was no
significant difference between non-cancer
patients and cancer patients in the relative
concentration of T cells (P > 0 2).
TABLE I.-Lymphocyte counts (mean x 10-9/1 + s.d.) of cancer patients and patients with
other diseases
C'ancer patients
Non-cancer patients
Age (years)
it AM/F (mean +s.d.)
16 7/9 64-4+11-6
7 4/3 60-3 + 19-5
Venouis blood
1 390+ 0-87l
1 *598 + 0 333
J'leuira1 effusion
0-841 + 0-716
0 097 + 0090
TABLE II. Lymphocyte subpopulations in pleural effusions (PE) and venous blood (IVB)
from cancer and non-cancer patients
Group
Noni-cancer
Canccr
-Non-eancer
(ancer
Source
VB
PE
PE
VIB
NNo. of
patients
7
16
7
1 (
T cells
(0/)
72-7+ 8-4
70-3 + 16-9
65-7 + 18-6
65-1 + 11-6
B cells
(0)
20-9+ 5-0
20-8+ 13-4
24-0± 14-7
24-5+ 8-1
Nuill cells
(o)
6-4+ 6-1
8-9_+ 7-7
10-3 ± 6-3
10 4+5-9
T/B
3-48
3-38
2-74
2-68
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When the proportion of T cells in
peripheral blood was compared with that
in pleural effusions, there was no signifi-
cant difference in the group of cancer
patients (P> 0.05) though the proportion
was higher in pleural effusions. The
effusions of non-cancer patients also re-
vealed a slightly higher proportion of T
cells than in their venous blood, but the
difference was also not statistically sig-
nificant (P > 0.2) (Table II).
The B-cell (SIgBC) counts in peripheral
blood of cancer patients (mean: 0-334 x
109/1) did not differ (P > 0-2) from those of
non-cancer patients (mean: 0 340 x 109/1).
Both values, however, were higher than in
young healthy persons (P < 0-01). Especi-
ally was the T-cell/B-cell ratio found to be
much lower (Table II).
Pleural effusions also showed about the
same relative concentrations of B cells in
cancer patients and non-cancer patients
(P > 0-2).
Cancer patients showed slightly lower
B-cell proportions in pleural effusions than
in venous blood (P > 0.05). A similar
difference in non-cancer patients was also
not significant (P > 04 1) (Table II).
We found a lower proportion of marker-
silent cells (so-called "null" cells) (Non-
RFC and Non-SIgBC) in the lymphocytes
in the venous blood and pleural effusions
of cancer and non-cancer patients than in
young healthy persons (P < 0.01). Venous
blood of non-cancer patients especially
contained few null cells (Table II).
Response to PHA
Lymphocytes from peripheral blood of
cancer and non-cancer patients revealed
lower transformation indices (TI) than in
young healthy donors (P < 0.01) but were
indistinguishable from those of healthy
persons of the same age group (Yama-
mura, 1.973; Barnes et al., 1975). Lympho-
cytes from pleural effusions from non-
cancer patients showed even lower TIs
(P < 0-001).
The lymphocytes from the venous blood
and the pleural effusions of cancer patients
clearly showed higher rates of DNA
synthesis in the unstimulated state than
lymphocytes from both blood and effusions
of non-cancer patients (P < 0-01; Table
III). Consequently, cancer patients'
pleural effusions had the lowest TI of all
the lymphocyte sources.
Proteins and immunoglobulins
Cancer patients showed higher levels of
TABLE III.-PHA-stimulated DANA synthesi,s in cultured lymphocytes from pleural
effusions and venous blood of cancer and non-cancer patients
Group Source
Non-cancer VB
Cancer VB
Non-cancer PE
Cancer PE
* Tl = (1/mn PHA-stimulate(d
d/min unstimulatedl
No. of
patients
3
12
3
12
[3H]-dT uptake (d/miln)
(mean+ s.d.)
UnstimuLlated PHA stimulated
744+ 212 22115+ 16263
2249 + 2509 43030 + 38321
995 + 307 14432+ 15314
2820+ 2418 15847+ 15839
TABLE IV. Protein and immunoylobulin concentrations in serum and pleural effusions
from cancer and non-cancer patients
Source of piroteill
Serum
Serum
Pleural effusion
I'leural effusion
Total
No. of protein
patients (mg/I)
16 67-98
7 64-25
16 38-00
7 23-06
Immunoglobuilin (%)
G+A+M IgG IgA IgM
20-3 14-9 3-7 1-7
31-1 24-6 4-6 1-9
20-0 15-5 3-3 1-2
14-6 11-6 22 0-8
TI*
29-7
19-1
15-4
5-6
Group
Cancer
Non-cancer
Cancer
Non-cancer
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total protein (P < 0.005) and of IgG, IgA,
and IgM (P < 0.002) in their pleural
effusions than non-cancer patients and
lower Ig levels in their sera than in non-
cancer patients (P < 0.05) (Table IV).
DISCUSSION
Lymphocyte-rich pleural effusions occur
in 15% of cancer patients whose cancer
has spread to this organ (Steinmann, un-
published). In patients in whom a pleural
effusion has been acquired for a reason
other than cancer, lymphocyte-rich pleural
effusions are only occasional. This fact
leads to the hypothesis that the malignant
cells themselves were responsible for the
gathering of lymphocytes, and also that
they attracted certain subpopulations
(Djeu et al., 1976).
In metastatic pleural effusions from
cancer patients, the distribution of B, T,
and null lymphocytes was found to be
nearly identical to that in the group of
patients with benign diseases complicated
by pleural effusions. There was a slight but
not significant tendency for T cells to occur
in higher numbers in metastatic pleural
effusions. This does not confirm the report
of Djeu et al. (1976) that the lymphocytes
in metastatic pleural effusions were pre-
dominantly T cells. This discrepancy
might be due to the use of a different RFC
assay or to contamination by macrophages
or tumour cells in the effusions examined
by these authors.
In venous blood of cancer patients, we
found a decreased percentage of RFC,
which might correspond to a lower T-cell-
mediated immune competence than in
patients with benign diseases and healthy
persons in the same age group. This
observation agrees with previous reports
(Wybran & Fudenberg, 1973; Oldham et
al., 1976). In contrast, there were no sig-
nificant differences between cancer and
non-cancer patients in the number of B
cells in venous blood anid pleural effusions.
This agrees with the observatioin that
cancer patients show no detectable evi-
dence of decreased immunoglobulin syn-
thesis (Aizawa & Southam, 1960).
The peripheral B-cell counts of both
cancer patients and non-cancer patients
were slightly higher than in younger
healthy volunteers, probably due to the
greater age.
We found higher levels of proteins and
immunoglobulins in metastatic pleural
effusions of cancer patients than in non-
cancer patients, which did not parallel the
B-cell counts in these effusions, suggesting
that the Igs in the effusions of cancer
patients were not only produced by the B
cells in these effusions. The lower level of
Ig in the serum ofthe cancer patients with
pleural effusions than in non-cancer
patients also supports the hypothesis of
an intensive transport of Ig from the
serum to the pleural effusion. It would be
ofinterest to analyse why these antibodies
are so ineffective in the defence of malig-
nant cells (Mitchison, 1977).
PHA-stimulated DNA synthesis in
blood lymphocytes of cancer patients and
other patients has already been investi-
gated by numerous research groups
(Barnes et al., 1975; Han & Takita, 1972;
Hoppe et al., 1977; Pary & Bone, 1973;
Rees et al., 1975; Reis et al., 1977; Robin-
son et al., 1974; Whitcomb & Parker,
1977). Most of the authors found that
PHA-stimulated DNA synthesis in blood
lymphocytes of patients with early-stage
cancer was reduced slightly if at all. A
clear reduction in DNA synthesis was not
found until preterminal stages and after
radiation therapy. We also did not observe
a significant difference in DNA synthesis
by blood lymphocytes between cancer
patients and non-cancer patients. On the
other hand, we found a significantly in-
creased rate of spontaneous DNA syn-
thesis in the lymphocytes of both periph-
eral blood and pleural effusions from
cancer patients.
Several years ago, Lopes Cardozo &
Harting (1972) described the PHA-
induced blast transformation of lympho-
cytes from metastatic pleural effusions. In
contrast to our study, they used only
morphological criteria of blast trans-
formation, which they reported was gener-
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ally good, even when the patients had
been treated with chemotherapeutic
agents.
In our study, the lymphocytes from
malignant pleural effusions showed a dis-
tinctly smaller increase in the rate ofDNA
synthesis in response toPHAthan lympho-
cytes from benign pleural effusions. This
difference was even greater when the
lymphocytes ofmalignant pleural effusions
were compared with blood lymphocvtes.
The transformation index (TI) of lympho-
cytes of malignant pleural effusions was
30%0 ofthe TI oflymphocytes from benign
pleural effusions, 25% of the TI of blood
lymphocytes from the same cancer
patients, and 16% of the TI of blood
lymphocytes from non-cancer patients.
The low TI of the lymphocytes from
metastatic pleural effusions in our studies
was influenced by the relatively high rate
of spontaneous DNA synthesis. Since T
lymphocytes respond to stimulation by
allogeneic antigens (Clot et al., 1975)
stimulation by tumour antigens or by
other antigens in cancer-associated
diseases might be responsible for the high
rate of spontaneous DNA synthesis, since
the rate ofspontaneous synthesis by blood
lymphocytes from cancer patients was
also high. This hypothesis is supported by
findings of Robinson et al. (1974), who
studied the stimulation of blood lympho-
cytes by tumour cells from pleural
effusions, and found a relatively low de-
gree of additional stimulation by PHA.
The rate of PHA-stimulated DNA syn-
thesis in lymphocytes from benign pleural
effusions was also relatively low, suggest-
ing additional cancer independent factors
suppressing the PHA response in pleural-
effusion lymphocytes. Robinson et al.
(1974) considered the possibility of a
factor in pleural effusions that could
inhibit the stimulation of lymphocytes.
This factor was speculative, but might be
similar to the one in mouse ascites, which
prolongs the survival of allografts (Biran
et al., 1969).
While our immunological characteriza-
tion of lymphocytes in lymphocyte-rich
pleural effusions of cancer and non-cancer
patients did not show any major differ-
ences in relative B- and T-cell contents,
the analysis of the more functional para-
meters spontaneous DNA synthesis, PHA-
stimulated DNA synthesis, and Ig content
revealed an enhanced activity of lympho-
cytes of both T and B lineage in meta-
static pleural effusions.
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